Prophylactic Topical Antibiotics in Fracture Repair and Spinal Fusion

Eric K Kim; Claire A Donnelley; Madeline Tiee; Heather J Roberts; Ericka Von Kaeppler; David Shearer; Saam Morshed

doi:10.1155/2021/1949877

Prophylactic Topical Antibiotics in Fracture Repair and Spinal Fusion

Adv Orthop. 2021 Oct 14:2021:1949877. doi: 10.1155/2021/1949877. eCollection 2021.

Authors

Eric K Kim¹, Claire A Donnelley², Madeline Tiee¹, Heather J Roberts³, Ericka Von Kaeppler², David Shearer³, Saam Morshed^{3

4}

Affiliations

¹ University of California San Francisco, School of Medicine, San Francisco, California, USA.
² Institute for Global Orthopaedics and Traumatology, Department of Orthopaedics, University of California, San Francisco, California, USA.
³ University of California San Francisco, Department of Orthopaedic Surgery, San Francisco, California, USA.
⁴ University of California San Francisco, Department of Epidemiology and Biostatistics, San Francisco, California, USA.

Abstract

Introduction: The objective of this systematic review with meta-analysis is to determine whether prophylactic local antibiotics prevent surgical site infections (SSIs) in instrumented spinal fusions and traumatic fracture repair. A secondary objective is to investigate the effect of vancomycin, a common local antibiotic of choice, on the microbiology of SSIs.

Methods: An electronic search of PubMed, EMBASE, and Web of Science databases and major orthopedic surgery conferences was conducted to identify studies that (1) were instrumented spinal fusions or fracture repair and (2) had a treatment group that received prophylactic local antibiotics. Both randomized controlled trials (RCTs) and comparative observational studies were included. Meta-analysis was performed separately for randomized and nonrandomized studies with subgroup analysis by study design and antibiotic.

Results: Our review includes 44 articles (30 instrumented spinal fusions and 14 fracture repairs). Intrawound antibiotics significantly decreased the risk of developing SSIs in RCTs of fracture repair (RR 0.61, 95% CI: 0.40-0.93, I ² = 32.5%) but not RCTs of instrumented spinal fusion. Among observational studies, topical antibiotics significantly reduced the risk of SSIs in instrumented spinal fusions (OR 0.34, 95% CI: 0.27-0.43, I ² = 52.4%) and in fracture repair (OR 0.49, 95% CI: 0.37-0.65, I ² = 43.8%). Vancomycin powder decreased the risk of Gram-positive SSIs (OR 0.37, 95% CI: 0.27-0.51, I ² = 0.0%) and had no effect on Gram-negative SSIs (OR 0.95, 95% CI: 0.62-1.44, I ² = 0.0%).

Conclusions: Prophylactic intrawound antibiotic administration decreases the risk of SSIs in fracture surgical fixation in randomized studies. Therapeutic efficacy in instrumented spinal fusion was seen in only nonrandomized studies. Vancomycin appears to be an effective agent against Gram-positive pathogens. There is no evidence that local vancomycin powder is associated with an increased risk for Gram-negative infection.

Publication types

Review